IL102525A - Preparation of inactivated-virus immunoglobulin solutions - Google Patents

Preparation of inactivated-virus immunoglobulin solutions

Info

Publication number
IL102525A
IL102525A IL10252592A IL10252592A IL102525A IL 102525 A IL102525 A IL 102525A IL 10252592 A IL10252592 A IL 10252592A IL 10252592 A IL10252592 A IL 10252592A IL 102525 A IL102525 A IL 102525A
Authority
IL
Israel
Prior art keywords
preparation
inactivated
immunoglobulin solutions
virus immunoglobulin
virus
Prior art date
Application number
IL10252592A
Other languages
English (en)
Other versions
IL102525A0 (en
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6437560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL102525(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of IL102525A0 publication Critical patent/IL102525A0/xx
Publication of IL102525A publication Critical patent/IL102525A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017Filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088Liquid substances
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/20Partition-, reverse-phase or hydrophobic interaction chromatography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL10252592A 1991-08-02 1992-07-16 Preparation of inactivated-virus immunoglobulin solutions IL102525A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125625A DE4125625C2 (de) 1991-08-02 1991-08-02 Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen

Publications (2)

Publication Number Publication Date
IL102525A0 IL102525A0 (en) 1993-01-14
IL102525A true IL102525A (en) 2005-05-17

Family

ID=6437560

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10252592A IL102525A (en) 1991-08-02 1992-07-16 Preparation of inactivated-virus immunoglobulin solutions

Country Status (14)

Country Link
US (1) US5648472A (cs)
EP (1) EP0525502B2 (cs)
JP (1) JP2969310B2 (cs)
KR (1) KR100188448B1 (cs)
AT (1) ATE143812T1 (cs)
CZ (1) CZ291813B6 (cs)
DE (2) DE4125625C2 (cs)
DK (1) DK0525502T4 (cs)
ES (1) ES2092604T5 (cs)
FI (1) FI107122B (cs)
IL (1) IL102525A (cs)
SK (1) SK280680B6 (cs)
YU (1) YU48242B (cs)
ZA (1) ZA925764B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
DK0911037T3 (da) 1997-10-23 2002-12-02 Mitsubishi Pharma Corp Ved stuetemperatur lagringsholdbart immunoglobulinpræparat til intravenøs injektion
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
ATE418347T1 (de) 2002-02-19 2009-01-15 Resolution Chemicals Ltd Auf lösungsmitteln basierende sterilisation von steroiden
DE602004020632D1 (de) * 2003-08-12 2009-05-28 Octapharma Ag Verfahren zur herstellung einer alpha-1-antitrypsinlösung
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
ES2407380T5 (es) 2004-02-27 2017-07-07 Octapharma Ag Procedimiento para proporcionar una preparación de anticuerpos purificada, sin riesgo respecto a virus
RU2352358C1 (ru) * 2007-10-04 2009-04-20 Наталия Васильевна Зубкова Способ приготовления вирусинактивированных растворов иммуноглобулинов
FR2944281B1 (fr) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique Derives soufres de resorcinol, leur preparation et leurs utilisations cosmetiques
PE20201167A1 (es) 2017-09-18 2020-10-28 Bayer Healthcare Llc Metodos de inactivacion de virus utilizando n-metilglutamida y sus derivados
AU2018357917B2 (en) 2017-10-30 2024-08-01 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography

Also Published As

Publication number Publication date
FI107122B (fi) 2001-06-15
ES2092604T5 (es) 2006-03-01
YU74092A (sh) 1995-10-24
KR100188448B1 (ko) 1999-06-01
DK0525502T4 (da) 2005-09-19
DE59207324D1 (de) 1996-11-14
KR930004329A (ko) 1993-03-22
SK280680B6 (sk) 2000-06-12
FI923425A0 (fi) 1992-07-29
IL102525A0 (en) 1993-01-14
FI923425L (fi) 1993-02-03
ATE143812T1 (de) 1996-10-15
DK0525502T3 (da) 1997-03-17
DE4125625A1 (de) 1993-02-04
ZA925764B (en) 1993-04-28
CZ236992A3 (en) 1993-02-17
EP0525502B1 (de) 1996-10-09
ES2092604T3 (es) 1996-12-01
CZ291813B6 (cs) 2003-06-18
DE4125625C2 (de) 1999-12-02
US5648472A (en) 1997-07-15
YU48242B (sh) 1997-08-22
JP2969310B2 (ja) 1999-11-02
EP0525502A1 (de) 1993-02-03
SK236992A3 (en) 1995-01-12
EP0525502B2 (de) 2005-08-10
JPH05202100A (ja) 1993-08-10

Similar Documents

Publication Publication Date Title
IL102525A0 (en) Preparation of virus-inactivated immunoglobulin solutions
EP0606093A3 (en) Integrated semiconductor optical device and manufacturing method.
GR3025315T3 (en) Antiestrogens as hypoglycemic agents.
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
EP0333143A3 (en) Medicinal soaps
AU638969B2 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
EP0538898A3 (en) Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
EP0437243A3 (en) Semiconductor laser and process for fabricating the same
EP0346501A4 (en) Pharmaceutical preparation for treating immunodeficiency conditions
EP0560358A3 (en) Semiconductor laser and process for fabricating the same
EP0571624A4 (en) METHOD FOR CONTROLLING THE HEIGHT OF A TORCH WHEN CUTTING PLASMA.
EP0603724A3 (en) Thermoplastic elastomers and their preparation process.
ZA932843B (en) A method of producing a factor VIII preparation
GB9005230D0 (en) Method for incorporating lenses in conv.swimming goggles
NZ247406A (en) Treatment of osteoporosis with 1 alpha, 24(r)-dihydroxy-22(e)-dehydro-vitamin d3
EP0637201A4 (en) METHOD FOR INDUCING ANTI-TUMOR IMMUNITY.
EP0602841A3 (en) Process for manufacturing integrated circuits.
GR3003932T3 (cs)
GR3019015T3 (en) Process for the preparation of 1,1,1,2-tetra-fluoroethane.
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
EP0475201A3 (en) Process for granulating 2,2,6,6-tetramethylpiperindine-containing light stabilizer
EP0247429A3 (en) Process for the preparation of hardly shrinking moulding articles based on a polyester
EP0235904A3 (en) Treatment of allergy with thymopentin
EP0588032A3 (en) Process for forming implanted regions with lowered channeling risk on semiconductors

Legal Events

Date Code Title Description
HE Change of address of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired